中华航海医学与高气压医学杂志
中華航海醫學與高氣壓醫學雜誌
중화항해의학여고기압의학잡지
Chinese Journal of Nautical Medicine and Hyperbaric Medicine
2015年
5期
337-340
,共4页
唐瑛%李卫红%方以群%攸璞%李峰%张赛%陈文彬%包晓辰%焦勇
唐瑛%李衛紅%方以群%攸璞%李峰%張賽%陳文彬%包曉辰%焦勇
당영%리위홍%방이군%유박%리봉%장새%진문빈%포효신%초용
快速上浮脱险%减压病%炎症反应%中药药组
快速上浮脫險%減壓病%炎癥反應%中藥藥組
쾌속상부탈험%감압병%염증반응%중약약조
Fast buoyancy ascent escape%Decompression sickness%Inflammatory response%Chinese medicinal drug group
目的 观察3种中药组方对快速上浮脱险减压病大鼠肺组织炎症反应的影响,筛选出疗效确切的药组.方法 100只实验大鼠分为5组:正常组、模型组、1号药组、2号药组、3号药组,每组20只,3个给药组给予相应的中药配方颗粒灌胃,10 d后,除正常组外,其余各组模拟快速上浮脱险诱导减压病模型.观察各组大鼠生存率、肺组织病理、血清和肺组织IL-1、TNF-α的变化情况.结果 与模型组比较,3个给药组大鼠死亡率下降,2、3号药组肺泡壁增厚程度和肺间质充血水肿程度明显减轻.2号和3号药组血清中IL-1、TNF-α含量[(145.84 ±2.10) ng/L,(249.71 ±2.89) ng/L;(123.71 ±1.74) ng/L,(229.23 ±8.74) ng/L]与对照组[(183.18±2.41) ng/L,(300.33±6.03) ng/L]比较均显著下降,差异有统计学意义(P<0.01);组织匀浆中IL-1与TNF-α含量亦明显下降(P<0.01或P<0.05).结论 2、3号药组对快速上浮脱险减压病大鼠肺组织的炎症反应有明显的改善作用.本研究为2、3号药组用于减压病的治疗提供了实验依据支撑.
目的 觀察3種中藥組方對快速上浮脫險減壓病大鼠肺組織炎癥反應的影響,篩選齣療效確切的藥組.方法 100隻實驗大鼠分為5組:正常組、模型組、1號藥組、2號藥組、3號藥組,每組20隻,3箇給藥組給予相應的中藥配方顆粒灌胃,10 d後,除正常組外,其餘各組模擬快速上浮脫險誘導減壓病模型.觀察各組大鼠生存率、肺組織病理、血清和肺組織IL-1、TNF-α的變化情況.結果 與模型組比較,3箇給藥組大鼠死亡率下降,2、3號藥組肺泡壁增厚程度和肺間質充血水腫程度明顯減輕.2號和3號藥組血清中IL-1、TNF-α含量[(145.84 ±2.10) ng/L,(249.71 ±2.89) ng/L;(123.71 ±1.74) ng/L,(229.23 ±8.74) ng/L]與對照組[(183.18±2.41) ng/L,(300.33±6.03) ng/L]比較均顯著下降,差異有統計學意義(P<0.01);組織勻漿中IL-1與TNF-α含量亦明顯下降(P<0.01或P<0.05).結論 2、3號藥組對快速上浮脫險減壓病大鼠肺組織的炎癥反應有明顯的改善作用.本研究為2、3號藥組用于減壓病的治療提供瞭實驗依據支撐.
목적 관찰3충중약조방대쾌속상부탈험감압병대서폐조직염증반응적영향,사선출료효학절적약조.방법 100지실험대서분위5조:정상조、모형조、1호약조、2호약조、3호약조,매조20지,3개급약조급여상응적중약배방과립관위,10 d후,제정상조외,기여각조모의쾌속상부탈험유도감압병모형.관찰각조대서생존솔、폐조직병리、혈청화폐조직IL-1、TNF-α적변화정황.결과 여모형조비교,3개급약조대서사망솔하강,2、3호약조폐포벽증후정도화폐간질충혈수종정도명현감경.2호화3호약조혈청중IL-1、TNF-α함량[(145.84 ±2.10) ng/L,(249.71 ±2.89) ng/L;(123.71 ±1.74) ng/L,(229.23 ±8.74) ng/L]여대조조[(183.18±2.41) ng/L,(300.33±6.03) ng/L]비교균현저하강,차이유통계학의의(P<0.01);조직균장중IL-1여TNF-α함량역명현하강(P<0.01혹P<0.05).결론 2、3호약조대쾌속상부탈험감압병대서폐조직적염증반응유명현적개선작용.본연구위2、3호약조용우감압병적치료제공료실험의거지탱.
Objective To observe the effects of 3 Chinese medicinal drug formulas on the lung inflammatory response in the rats with decompression sickness induced by fast buoyancy ascent escape, and also to screen out the drug formula that had confirmed curative efficacy.Methods The experimental rats were randomly classified into 5 groups: the normal group, the model group, the No.1 drug group, the No.2 drug group and the No.3 drug group, each consisting of 20 animals.The 3 drug treatment groups were given Chinese medicinal drug granules by gavage.After 10 days, all the animal groups except the normal group underwent simulated fast buoyancy ascent escape to develop the decompression sickness model.Then, close observation was made on the survival rate, lung tissue pathology, and changes in the levels of IL-1and TNF-α in the animals of various groups.Results As compared with that of the model group, survival rates of the rats in the 3 drug treatment groups were increased.Thickening of the alveolar wall and pulmonary interstitial edema were obviously alleviated in the rats of the No.2 and No.3 groups, and the levels of IL-1 and TNF-oα in serum and tissue homogenate were all obviously decreased.Conclusions The No.2 and No.3 drug formals could obviously alleviate lung inflammatory response of the rats with DSC induced by the fast buoyancy ascent escape.This study provided experimental evidence for the application of No.2 and No.3 drug formulas in the treatment of DCS.